CA2047363C - Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs - Google Patents

Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs Download PDF

Info

Publication number
CA2047363C
CA2047363C CA002047363A CA2047363A CA2047363C CA 2047363 C CA2047363 C CA 2047363C CA 002047363 A CA002047363 A CA 002047363A CA 2047363 A CA2047363 A CA 2047363A CA 2047363 C CA2047363 C CA 2047363C
Authority
CA
Canada
Prior art keywords
acting regulatory
host cell
cis
construct
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002047363A
Other languages
English (en)
Other versions
CA2047363A1 (fr
Inventor
Mark A. Goldsmith
Robert O. Ralston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP97113730A priority Critical patent/EP0832980B1/fr
Priority to JP2503423A priority patent/JP2752788B2/ja
Priority to PCT/US1990/000445 priority patent/WO1990007936A1/fr
Priority to EP90902891A priority patent/EP0454781B1/fr
Application filed by Chiron Corp filed Critical Chiron Corp
Priority to CA002047363A priority patent/CA2047363C/fr
Publication of CA2047363A1 publication Critical patent/CA2047363A1/fr
Application granted granted Critical
Publication of CA2047363C publication Critical patent/CA2047363C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002047363A 1989-01-23 1991-07-18 Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs Expired - Fee Related CA2047363C (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP97113730A EP0832980B1 (fr) 1989-01-23 1990-01-22 Thérapie recombinante des infections et désordres hyperprolifératifs
JP2503423A JP2752788B2 (ja) 1989-01-23 1990-01-22 感染および過剰増殖障害の為の組換え療法
PCT/US1990/000445 WO1990007936A1 (fr) 1989-01-23 1990-01-22 Therapies de recombinaison pour infections et troubles hyperproliferatifs
EP90902891A EP0454781B1 (fr) 1989-01-23 1990-01-22 Cellules de recombinaison pour des therapies d'infections et de troubles hyperproliferatifs et la preparation de ces cellules
CA002047363A CA2047363C (fr) 1989-01-23 1991-07-18 Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30063789A 1989-01-23 1989-01-23
CA002047363A CA2047363C (fr) 1989-01-23 1991-07-18 Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs

Publications (2)

Publication Number Publication Date
CA2047363A1 CA2047363A1 (fr) 1993-01-19
CA2047363C true CA2047363C (fr) 2001-07-03

Family

ID=25674701

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047363A Expired - Fee Related CA2047363C (fr) 1989-01-23 1991-07-18 Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs

Country Status (1)

Country Link
CA (1) CA2047363C (fr)

Also Published As

Publication number Publication date
CA2047363A1 (fr) 1993-01-19

Similar Documents

Publication Publication Date Title
US5861290A (en) Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
EP0832980B1 (fr) Thérapie recombinante des infections et désordres hyperprolifératifs
EP0415731B1 (fr) Substances nouvelles pour la thérapie du cancer
CA2234931C (fr) Nouveaux vecteurs d'expression et procedes d'utilisation correspondants
EP0702084B1 (fr) Rétrovirus recombinants
Brenner et al. Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy
Von Rüden et al. Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA
US6200811B1 (en) Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein
US20150216948A1 (en) Cytochrome p450 suicide gene system
WO1997034638A1 (fr) Approche anti-sens de l'inhibition des genes
Ragheb et al. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev
KR20010084913A (ko) 폴리뉴클레오티드 컨스트럭트 및 그의 용도
CA2047363C (fr) Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs
US20060223775A1 (en) Nucleotide sequence for treating cancer and infection
CA2261987C (fr) Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes
JPH10506007A (ja) 機能修飾されたｈｓｖ１−ｔｋ
EP0716710B1 (fr) Procedes de suppression de la reponse immunitaire par therapie genique
OBARU et al. Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1
Fujita et al. Selective inhibition of human T-lymphotropic virus type I-transformed human T-cell growth by a tax-targeted conditionally cytotoxic recombinant retrovirus
US6953687B1 (en) Vectors for delivering viral and oncogenic inhibitors
EP0977881B1 (fr) Expression d'une proteine d'enveloppe modifiee de virus spumeux
JP2003530855A (ja) 遺伝子治療のためのベクター
US20030091546A1 (en) Methods of suppressing immune response by gene therapy
JPWO2009051078A1 (ja) 治療用遺伝子発現システム
JP2001520017A (ja) ヒト免疫不全ウイルス（ｈｉｖ−１）複製の阻害

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed